The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes.

Diabetes Care
Ronald B GoldbergScott M Grundy

Abstract

The American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines recently published its 2018 recommendations on management of LDL cholesterol (LDL-C) in people with diabetes. For primary prevention, moderate-intensity statin therapy is recommended for those aged 40-75 years, with a preference for high-intensity statin treatment for older subjects and for those with higher estimated risk or risk-enhancing factors following a patient-clinician discussion. Statin therapy may be reasonable in adults <40 years or >75 years of age where there is less evidence for benefit. For people with diabetes and established atherosclerotic cardiovascular disease, high-intensity statin therapy is recommended. The majority of these subjects have very high risk, and an LDL-C goal of <70 mg/dL is recommended. If this target is not achieved, ezetimibe and/or a proprotein convertase subtilisin/kexin type 9 inhibitor may be added.

References

Jan 15, 2005·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M OgrenL Janzon
Jul 22, 2005·The New England Journal of Medicine·Christoph WannerUNKNOWN German Diabetes and Dialysis Study Investigators
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Mar 2, 2012·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Nathan D WongUchenna Iloeje
Sep 5, 2013·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Maria K SvenssonUNKNOWN Swedish National Diabetes Register
Jun 4, 2015·The New England Journal of Medicine·Christopher P CannonUNKNOWN IMPROVE-IT Investigators
Dec 17, 2015·Journal of General Internal Medicine·Jamal S RanaAndrew J Karter
Apr 14, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Vivian Yawei GuoBenny Chung-Ying Zee
Aug 2, 2016·The Lancet. Diabetes & Endocrinology·UNKNOWN Cholesterol Treatment Trialists' (CTT) CollaborationColin Baigent
Feb 25, 2017·Journal of the American College of Cardiology·Erin A BohulaEugene Braunwald
Mar 1, 2017·JAMA : the Journal of the American Medical Association·Dana DabeleaUNKNOWN SEARCH for Diabetes in Youth Research Group
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
Nov 8, 2018·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN ODYSSEY OUTCOMES Committees and Investigators
Nov 13, 2018·The New England Journal of Medicine·Deepak L BhattUNKNOWN REDUCE-IT Investigators
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jan 20, 2021·Current Atherosclerosis Reports·Jan Škrha
Nov 27, 2020·Diabetes Research and Clinical Practice·Muhammad Q MasoodUNKNOWN CARRS Trial Group
Jun 22, 2021·Circulation Journal : Official Journal of the Japanese Circulation Society·Shun KohsakaShintaro Nakano
Sep 10, 2021·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Margaret McCarthyVictoria Vaughan Dickson

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.